Register Today for the 26th ASGCT Annual Meeting
The ASGCT Board of Directors and the Society's officers have full responsibility for the management, direction and control of the business, policies and affairs of ASGCT, subject only to limitations set forth in the Society's Articles of Incorporation and Bylaws. Learn more about the Board and Officers below.
Hans-Peter Kiem, MD, PhD, President
Jeffrey Chamberlain, PhD, President Elect
Paula Cannon, PhD, Vice President
Isabelle Riviere, PhD, Secretary
Paloma Giangrande, PhD, Treasurer
Aravind Asokan, PhD
Hildegard Büning, PhD
Lindsey George, MD
Anastasia Khvorova, PhD
Marcela Maus, MD, PhD
Federico Mingozzi, PhD
Maria-Grazia Roncarolo, MD
Rayne Rouce, MD
Jennifer Wellman, MS
Beverly L. Davidson, PhD, Immediate Past President
Roland W. Herzog, PhD, Ex-Officio
In order to better meet the increasing needs of our different constituencies, ASGCT embarked on a strategic planning summit in 2015. Learn more about the five goals of the Society.
Read the full Society Bylaws, which were amended and restated in May 2017.
May 16-20 | Los Angeles, CA
© 2000-2023 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico